Although accumulating evidence suggests that overexpressed TM4SF1 can contribute to the development, progression, and drug resistance of many malignant tumors, the biological functions and involved mechanisms of TM4SF1 in ESCC remain largely unknown. This evidence concerns the gene TM4SF1 and esophageal squamous cell carcinoma.